FRANCISCO JAVIER
LÓPEZ LONGO
Investigador hasta 2019
Norberto
Ortego Centeno
Publicaciones en las que colabora con Norberto Ortego Centeno (19)
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Influence of MUC5B gene on antisynthetase syndrome
Scientific Reports, Vol. 10, Núm. 1
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
-
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome
Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49
2017
-
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
Scientific Reports, Vol. 7
-
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study
Autoimmunity Reviews, Vol. 16, Núm. 3, pp. 253-257
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
2006
-
Registrolesaf. Características de los pacientes con lupus eritematoso sistémico síndrome antifosfolipídico registrados por usuarios médicos especialistas en reumatología y medicina interna
Reumatologia Clinica, Vol. 2, Núm. 3, pp. 131-136